| NCT02064777 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Pediatric Liver Transplantation | 2013-07 | PHASE4 |
| NCT03365141 | The Catholic University of Korea | Vitiligo|Treatment|Intralesional Injection|Corticosteroid | 2017-11-14 | NA |
| NCT00611351 | University of Nebraska|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Secondary Myelofibrosis | 2005-06-07 | PHASE2 |
| NCT05666336 | Fen Li | Systemic Lupus Erythematosus | 2022-12-31 | PHASE4 |
| NCT03437577 | University of Minnesota | Kidney Transplant Failure and Rejection | 2018-05-08 | PHASE1|PHASE2 |
| NCT06365437 | ITB-Med LLC | Kidney Transplantation | 2021-06-06 | PHASE2 |
| NCT00545402 | Hoffmann-La Roche | Liver Transplantation | 2007-11 | PHASE4 |
| NCT01350245 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Acute Myeloid Leukemia|Myelodysplastic Syndromes|Biphenotypic Leukemia|Acute Lymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Lymphocytic Leukemia|Plasma Cell Neoplasms|Lymphoma|Hodgkin´s Disease|Aplastic Anemia | 2010-07 | PHASE2 |
| NCT05667922 | Qianfoshan Hospital | Idiopathic Membranous Nephropathy | 2023-06 | |
| NCT00801957 | Astellas Pharma Inc | Atopic Dermatitis | 2003-03 | PHASE2 |
| NCT00125307 | Chinese University of Hong Kong | Lupus Nephritis|Lupus Erythematosus, Systemic | 2004-01 | PHASE4 |
| NCT02147938 | Astellas Pharma S.A.S. | Renal Transplantation | 2014-07-17 | |
| NCT06287944 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndrome | 2025-07-01 | PHASE1 |
| NCT00195429 | Wyeth is now a wholly owned subsidiary of Pfizer | Kidney Failure|Graft vs Host Disease | 2005-08 | PHASE4 |
| NCT00189761 | Astellas Pharma Inc | Bone Marrow Transplantation|Graft Versus Host Disease|Graft-Vs-Host Disease|Graft-Versus-Host Disease | | PHASE2 |
| NCT02936505 | Vastra Gotaland Region|Oslo University Hospital|Helsinki University Central Hospital|Skane University Hospital|Copenhagen University Hospital, Denmark | Lung Transplantation|Allografts | 2016-10-12 | NA |
| NCT00121186 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Lymphoma | 2005-07 | PHASE2 |
| NCT00885820 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Kidney Transplantation | 2001-09 | PHASE4 |
| NCT04521946 | M.D. Anderson Cancer Center | Anaplastic Ependymoma|Atypical Teratoid+Rhabdoid Tumor|Central Nervous System Germ Cell Tumor|Choroid Plexus Carcinoma|Intracranial Myeloid Sarcoma|Malignant Brain Neoplasm|Malignant Glioma|Medulloblastoma|Primitive Neuroectodermal Tumor|Recurrent Anaplastic Ependymoma|Recurrent Atypical Teratoid+Rhabdoid Tumor|Recurrent Malignant Brain Neoplasm|Recurrent Malignant Glioma|Recurrent Medulloblastoma|Recurrent Primitive Neuroectodermal Tumor | 2021-01-14 | PHASE1 |
| NCT01224418 | Astellas Pharma Inc|Astellas Pharma Korea, Inc. | Rheumatoid Arthritis | 2008-05 | PHASE4 |
| NCT01511003 | Astellas Pharma Inc|Astellas Pharma Korea, Inc. | Rheumatoid Arthritis | 2011-12-05 | PHASE4 |
| NCT01619761 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|ISS Stage II Plasma Cell Myeloma|ISS Stage III Plasma Cell Myeloma|Myelodysplastic Syndrome|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma|Secondary Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia|Therapy-Related Myelodysplastic Syndrome | 2013-05-03 | PHASE1 |
| NCT00787761 | Northside Hospital, Inc.|Blood and Marrow Transplant Group of Georgia | Myeloproliferative Disorders|Kidney Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2007-04 | PHASE2 |
| NCT05457556 | Children´s Oncology Group | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome | 2023-03-15 | PHASE3 |
| NCT03865888 | Pavly Moawd | Dry Eye|Sjogren Syndrome | 2018-10-30 | PHASE3 |
| NCT01810588 | Weill Medical College of Cornell University | Hematologic Malignancies | 2012-10-16 | PHASE2 |
| NCT03663933 | National Cancer Institute (NCI) | Lymphoproliferative Disorders|Autoimmune Lymphoproliferative|Primary T-cell Immunodeficiency Disorders|Immune System Diseases|Common Variable Immunodeficiency | 2018-09-04 | PHASE2 |
| NCT01256398 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | 2010-12-14 | PHASE2 |
| NCT04182984 | Tang-Du Hospital | Ocular Myasthenia Gravis | 2019-11-04 | |
| NCT03263052 | University of Illinois at Chicago|Veloxis Pharmaceuticals | Disorder Related to Renal Transplantation | 2017-07-01 | |
| NCT01139450 | Fougera Pharmaceuticals Inc. | Atopic Dermatitis | 2008-01 | PHASE3 |
| NCT00757874 | Deana Funaro|Astellas Pharma Inc | Vulvar Lichen Sclerosus | 2006-04 | PHASE2 |
| NCT01318915 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Renal Transplant Recipients | 2011-07-25 | EARLY_PHASE1 |
| NCT03128359 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Leukemia|Chronic Lymphocytic Leukemia+Small Lymphocytic Lymphoma|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Diffuse Large B-Cell Lymphoma|Follicular Lymphoma|Graft Versus Host Disease|Hodgkin Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma|Secondary Myelodysplastic Syndrome | 2017-05-30 | PHASE2 |
| NCT02683291 | Associa??o Médico Espírita de Botucatu | Disorder Related to Renal Transplantation|Cytomegalovirus Infections | 2014-01 | PHASE4 |
| NCT00538265 | University Hospital, Toulouse | Liver Transplantation | 2005-05 | PHASE4 |
| NCT00779792 | Odense University Hospital|LEO Pharma|University of Southern Denmark | Dermatitis, Contact|Dermatitis, Occupational | 2008-09 | PHASE4 |
| NCT03605927 | H. Lee Moffitt Cancer Center and Research Institute|Bristol-Myers Squibb | Graft-versus-host-disease|GVHD|GVHD, Acute | 2019-02-15 | PHASE1 |
| NCT00076570 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Kidney Transplantation | 2004-01 | PHASE2 |
| NCT03734601 | Stanford University | Acute Myeloid Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorder|Chronic Lymphocytic Leukemia|B-cell Lymphoma|T-cell Lymphoma|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Chronic Myelomonocytic Leukemia | 2018-11-05 | PHASE2 |
| NCT00350545 | Stanford University | Graft vs Host Disease | 2006-08 | NA |
| NCT00445744 | Fred Hutchinson Cancer Center|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Essential Thrombocythemia|Myelodysplastic Syndrome With Isolated Del(5q)|Polycythemia Vera|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Secondary Myelofibrosis|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies | 2006-12 | NA |
| NCT01678937 | Northwestern University|Northwestern Memorial Hospital | Liver Transplant Rejection|Immunosuppression | 2007-09 | |
| NCT01120028 | University of Oxford|National Health Service, United Kingdom|Pfizer|Novartis | Kidney Transplantation | 2010-09 | PHASE2|PHASE3 |
| NCT04420195 | NYU Langone Health | Lung Transplant | 2020-10-23 | PHASE2 |
| NCT00369226 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Millennium Pharmaceuticals, Inc. | Hematologic Malignancies | 2006-08 | PHASE1|PHASE2 |
| NCT01938625 | Janssen R&D Ireland | Hepatitis C, Chronic | 2013-12-12 | PHASE2 |
| NCT01244659 | EMS | Renal Transplant | 2014-05 | PHASE3 |
| NCT02820259 | Rennes University Hospital | Biliary Concentration of Tacrolimus | 2016-05-01 | |
| NCT05109390 | Alexion Pharmaceuticals, Inc.|Achillion, a wholly owned subsidiary of Alexion | Healthy | 2018-07-27 | PHASE1 |
| NCT00818961 | Northside Hospital, Inc.|Blood and Marrow Transplant Group of Georgia | Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2005-05 | PHASE2 |
| NCT00553202 | Children´s Oncology Group|National Cancer Institute (NCI) | Leukemia | 2008-01 | PHASE2 |
| NCT03321656 | Roberto Gedaly|Veloxis Pharmaceuticals | End Stage Renal Disease | 2019-03-28 | PHASE2|PHASE3 |
| NCT01080456 | Panacea Biotec Ltd | Healthy Volunteers | 2007-09 | NA |
| NCT00296361 | Astellas Pharma Inc | Kidney Transplantation | 2004-10 | PHASE3 |
| NCT06880042 | Dr ayesha wahid | Vitiligo - Macular Depigmentation|Tacrolimus | 2025-05-01 | EARLY_PHASE1 |
| NCT01754389 | Dana-Farber Cancer Institute | Graft Versus Host Disease | 2013-01 | PHASE2 |
| NCT04205240 | Srinivas Devarakonda | Recurrent Plasma Cell Myeloma | 2020-12-22 | PHASE2 |
| NCT00004255 | Chimeric Therapies | Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes | 2000-03 | PHASE2|PHASE3 |
| NCT00880815 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | CD20 Positive|Chronic Lymphocytic Leukemia|Follicular Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|T-Cell Non-Hodgkin Lymphoma | 2009-02-17 | PHASE1 |
| NCT06807606 | M.D. Anderson Cancer Center | Hematologic Malignancies | 2025-03-03 | PHASE2 |
| NCT00317785 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2005-05 | PHASE2 |
| NCT00792948 | National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Adult L1 Acute Lymphoblastic Leukemia|Adult L2 Acute Lymphoblastic Leukemia|Adult T Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia | 2009-09-01 | PHASE2 |
| NCT00347048 | Astellas Pharma Inc | Ulcerative Colitis | 2006-09 | PHASE3 |
| NCT00378326 | Rockefeller University | Paraneoplastic Syndromes | 2006-04 | NA |
| NCT05294666 | Peking University Third Hospital | Graft Versus Host Disease in Eye | 2020-04-01 | PHASE4 |
| NCT03779854 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Biphenotypic Leukemia|Acute Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Undifferentiated Leukemia|Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Blastic Plasmacytoid Dendritic Cell Neoplasm|Blasts Under 25 Percent of Bone Marrow Nucleated Cells|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome With Excess Blasts-1|Myelodysplastic Syndrome+Acute Myeloid Leukemia|Burkitt Leukemia|Chronic Monocytic Leukemia|Lymphoblastic Lymphoma|Mast Cell Leukemia|Myeloproliferative Neoplasm | 2019-08-29 | PHASE2 |
| NCT01745159 | Astellas Pharma China, Inc. | Moderate+Severe Atopic Dermatitis | 2012-09 | PHASE4 |
| NCT03842696 | University of Michigan Rogel Cancer Center|National Institutes of Health (NIH)|National Center for Advancing Translational Sciences (NCATS) | Hematologic Diseases|Acute Leukemia in Remission|Chronic Myelogenous Leukemia - Chronic Phase|Chronic Myelogenous Leukemia, Accelerated Phase|Chronic Myelogenous Leukemia, Blastic Phase|Myelodysplastic Syndromes|Mantle Cell Lymphoma|Follicular Lymphoma|Diffuse Large B Cell Lymphoma|Non Hodgkin Lymphoma|Graft Vs Host Disease|Graft-versus-host-disease | 2020-02-04 | PHASE1|PHASE2 |
| NCT02188719 | National Institute of Allergy and Infectious Diseases (NIAID)|Rho Federal Systems Division, Inc. | Liver Transplantation | 2014-12-17 | PHASE1 |
| NCT04403321 | Peking Union Medical College Hospital | Aplastic Anemia|Drug Effect | 2020-07-01 | PHASE2 |
| NCT03088709 | Loyola University | Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome|Non-hodgkin Lymphoma|Chronic Lymphocytic Leukemia | 2017-01-18 | PHASE2 |
| NCT00317681 | Heinrich-Heine University, Duesseldorf | Cutaneous Lupus Erythematosus | 2005-08 | PHASE2 |
| NCT02918292 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network|National Marrow Donor Program | Severe Aplastic Anemia | 2017-07-03 | PHASE2 |
| NCT00028600 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Multiple Myeloma|Plasma Cell Neoplasm | 2001-11 | PHASE2 |
| NCT02411604 | Veloxis Pharmaceuticals | Renal Failure | | |
| NCT01802268 | Helio Tedesco Silva Junior|Pfizer | Kidney Transplant | 2008-02 | PHASE4 |
| NCT05364762 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Primary Myelofibrosis|Secondary Myelofibrosis | 2022-11-23 | PHASE2 |
| NCT06867042 | Jina Pharmaceuticals Inc.|Novum Pharmaceutical Research Services | Ulcerative Colitis (UC)|Ulcerative Colitis, Active Moderate | 2025-04 | PHASE2 |
| NCT01698541 | University of Oslo School of Pharmacy|Oslo University Hospital | End Stage Renal Disease | 2013-02 | PHASE4 |
| NCT03292861 | Cedars-Sinai Medical Center|Genzyme, a Sanofi Company | Heart Transplantation | 2018-09-13 | PHASE2 |
| NCT05983770 | Eledon Pharmaceuticals | Kidney Transplant Rejection | 2023-08-30 | PHASE2 |
| NCT02794610 | The Eye Center and The Eye Foundation for Research in Ophthalmology | Ocular Penetration of Topical Tacrolimus | 2016-05 | NA |
| NCT00544115 | City of Hope Medical Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Precancerous+Nonmalignant Condition | 2001-10-16 | PHASE2 |
| NCT00693524 | Astellas Pharma Inc | Liver Transplantation | 2002-11 | PHASE2 |
| NCT01701986 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Hematopoietic Cell Transplantation Recipient|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Hodgkin Lymphoma|Refractory T-Cell Non-Hodgkin Lymphoma | 2012-10-25 | PHASE1|PHASE2 |
| NCT01729494 | University of Cincinnati | Renal Transplantation | 2012-09 | PHASE4 |
| NCT00166829 | National Taiwan University Hospital | Kidney Transplantation | 2004-05 | PHASE4 |
| NCT02953873 | Medical University of South Carolina|Astellas Pharma Inc | Immunosuppression | 2017-05-05 | PHASE4 |
| NCT00133172 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Kidney Transplantation | 2005-07 | PHASE4 |
| NCT03171831 | First Affiliated Hospital of Guangxi Medical University | Thalassemia Major | 2017-04-01 | PHASE4 |
| NCT03076151 | University Hospital, Limoges | Transplantation|Kidney|Pharmacokinetic | 2018-02-12 | PHASE4 |
| NCT05202145 | Alexion Pharmaceuticals, Inc. | Healthy | 2022-01-11 | PHASE1 |
| NCT03864250 | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Tacrolimus|Idiopathic Membranous Nephropathy|Clinical Trial | 2018-11-26 | NA |
| NCT00934791 | Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer | Polycystic Liver Disease | 2009-02 | NA |
| NCT05153915 | Astellas Pharma China, Inc. | Liver Transplantation|Kidney Transplantation | 2021-12-30 | PHASE4 |
| NCT01927120 | H. Lee Moffitt Cancer Center and Research Institute | Graft-Versus-Host-Disease | 2014-03-25 | PHASE2 |
| NCT00118742 | Hoffmann-La Roche | Liver Transplantation | 2005-08 | PHASE4 |
| NCT00533442 | University of Miami|Astellas Pharma Inc | Type 1 Diabetes | 2000-09 | PHASE2 |
| NCT01911546 | Joseph Kahwaji, MD, MPH|Novartis | Highly-sensitized Kidney Transplant Recipients | 2013-06 | PHASE2 |
| NCT01256294 | Novartis|Sandoz | Renal Transplant | 2010-10 | PHASE4 |
| NCT01292525 | Nantes University Hospital | Function of Renal Transplant | 2011-05 | PHASE3 |
| NCT01187953 | Veloxis Pharmaceuticals | Renal Failure | 2010-09 | PHASE3 |
| NCT01135329 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Lymphoma|Leukemia|Myelodysplastic Syndrome | 2010-08 | PHASE2 |
| NCT00459719 | Astellas Pharma Inc | Liver Transplantation | 2007-03 | PHASE3 |
| NCT03918265 | Peking Union Medical College Hospital | Autoimmune Hemolytic Anemia|Pure Red Cell Aplasia|Evans Syndrome | 2019-05-04 | PHASE4 |
| NCT01824693 | Children´s Oncology Group|National Cancer Institute (NCI) | Juvenile Myelomonocytic Leukemia | 2013-06-24 | PHASE2 |
| NCT01773395 | Dana-Farber Cancer Institute|Massachusetts General Hospital|Beth Israel Deaconess Medical Center | Myelodysplastic Syndrome|Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia | 2013-01-08 | PHASE2 |
| NCT06996119 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia|Graft Versus Host Disease|Myelodysplastic Syndrome | 2026-05-25 | PHASE1 |
| NCT00023244 | National Institute of Allergy and Infectious Diseases (NIAID)|Cooperative Clinical Trials in Pediatric Transplantation | End-Stage Renal Disease | 2001-01 | PHASE2 |
| NCT05807932 | Heinrich-Heine University, Duesseldorf|Koordinierungszentrum für Klinische Studien - Duesseldorf | Myelodysplastic Syndromes|Secondary Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia | 2023-06-26 | PHASE1|PHASE2 |
| NCT02808065 | Seoul National University Hospital|Ministry of Food and Drug Safety, Korea | Kidney Transplantation | 2016-05 | |
| NCT02167958 | Rafic Farah, MD | Leukemia|MDS|Myelofibrosis|Lymphoma | 2015-02-11 | PHASE1 |
| NCT02961608 | Hospital Universitari de Bellvitge | Kidney Transplant; Complications | 2016-05 | PHASE4 |
| NCT01958190 | Foundation for Liver Research | Liver Disease | 2011-02-07 | PHASE4 |
| NCT04720326 | Edward Geissler|Chiesi Pharmaceuticals GmbH|Excelya | Prophylaxis Against Liver Transplant Rejection | 2020-12-23 | PHASE4 |
| NCT00777933 | Samsung Medical Center | Kidney Transplantation|Living Donors | 2000-07 | NA |
| NCT00589316 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|CD45-Positive Neoplastic Cells Present|Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndrome|Refractory Anemia With Excess Blasts|Refractory Anemia With Ring Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts | 2007-10-05 | PHASE1 |
| NCT00007787 | National Institute of Allergy and Infectious Diseases (NIAID) | Kidney Transplantation|Chronic Allograft Nephropathy | 2000-04 | NA |
| NCT00429143 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematologic Malignancies | 2006-01 | PHASE1|PHASE2 |
| NCT04154735 | Northwestern University | Crohn´s Disease | 2019-11 | PHASE2 |
| NCT03347357 | Shandong University | Nephrotic Syndrome | 2012-01-01 | PHASE4 |
| NCT03222687 | Shandong University | Henoch-Sch?nlein Purpura Nephritis | 2015-09-01 | PHASE4 |
| NCT00004878 | Jonsson Comprehensive Cancer Center | Graft Versus Host Disease|Leukemia | | PHASE2 |
| NCT00187915 | University of Florida|Hoffmann-La Roche | Transplant, Kidney | 2003-07 | NA |
| NCT02129582 | Case Comprehensive Cancer Center | Acute Myeloid Leukemia|Hematologic Malignancies|Acute Lymphocytic Leukemia|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Multiple Myeloma|Myelodysplastic Syndrome|Chronic Lymphocytic Leukemia|Chronic Myeloid Leukemia|Myelofibrosis|Myeloproliferative Syndrome | 2014-11-05 | PHASE1 |
| NCT02563782 | Astellas Institute for Regenerative Medicine | Age-Related Macular Degeneration | 2015-08-24 | PHASE2 |
| NCT02395497 | Johns Hopkins University | Amputation|Wounds and Injuries|Amputation, Traumatic|Urologic Surgical Procedures, Male|Amputation, Traumatic+Surgery|Penis+Transplantation|Penis+Surgery|Penis+Injuries|Congenital Anomaly, Male Genitalia | 2014-06 | PHASE2|PHASE3 |
| NCT03828682 | Simon Tremblay, PharmD, PhD|Veloxis Pharmaceuticals | Kidney Transplantation|Immunosuppression | 2019-06-21 | PHASE4 |
| NCT00609388 | Medical University of Vienna | Ischemia Reperfusion Injury | 2008-01 | PHASE4 |
| NCT01338987 | National Cancer Institute (NCI) | Myelodysplastic Syndrome|Acute Lymphocytic Leukemia|Acute Myelogenous Leukemia|Chronic Myelogenous Leukemia|Chronic Myelomonocytic Leukemia | 2011-04-19 | PHASE2 |
| NCT04127721 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Allogeneic Stem Cell Transplant Recipient|Hematologic and Lymphocytic Disorder|Hematopoietic and Lymphoid Cell Neoplasm | 2020-09-22 | PHASE2 |
| NCT00313625 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Multiple Myeloma and Plasma Cell Neoplasm | 2005-09 | PHASE2 |
| NCT00346359 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2006-03 | PHASE2 |
| NCT04390685 | Odense University Hospital | Lymphedema | 2020-02-26 | PHASE1|PHASE2 |
| NCT04258423 | Indiana University | Kidney Failure | 2019-12-19 | PHASE3 |
| NCT04747080 | Peking University People´s Hospital|Beijing Hospital|Beijing Friendship Hospital|China-Japan Friendship Hospital|The First Affiliated Hospital of Zhengzhou University|First Affiliated Hospital of Chongqing Medical University|Shanxi Bethune Hospital | ITP|Immune Thrombocytopenia | 2021-03-01 | PHASE2 |
| NCT02504359 | OHSU Knight Cancer Institute|Oregon Health and Science University | Plasma Cell Leukemia|Recurrent Plasma Cell Myeloma | 2015-07-20 | PHASE1 |
| NCT00833079 | Sun Pharmaceutical Industries, Inc. | Atopic Dermatitis | 2008-10 | PHASE1 |
| NCT07570433 | Oriol Manuel|Centre Hospitalier Universitaire Bordeaux|Centre Hospitalier Universitaire de Toulouse, FRANCE|Hospital Vall d´Hebron | CMV Infection | 2026-04 | PHASE4 |
| NCT00589563 | City of Hope Medical Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms|Precancerous Condition|Secondary Myelofibrosis|Small Intestine Cancer | 2007-05 | PHASE2 |
| NCT01049633 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | | |
| NCT01224041 | Astellas Pharma Inc|Astellas Pharma Korea, Inc. | Rheumatoid Arthritis | 2009-08 | PHASE4 |
| NCT06615050 | Incyte Corporation|Blood and Marrow Transplant Clinical Trials Network|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Graft-versus-host Disease (GVHD) | 2025-04-02 | PHASE3 |
| NCT02333162 | University of Chicago|National Cancer Institute (NCI) | Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Hematologic Malignancy | 2014-12-05 | PHASE1 |
| NCT00615173 | Sun Yat-sen University | Kidney Diseases|Lupus Nephritis|Tacrolimus|Induction Phase|Maintenance Phase | 2006-07 | PHASE3 |
| NCT00922129 | St. Joseph´s Healthcare Hamilton | Prostate Cancer | 2009-09 | PHASE2|PHASE3 |
| NCT02588339 | H. Lee Moffitt Cancer Center and Research Institute|Novartis | Graft Versus Host Disease|GVHD | 2016-03-04 | PHASE2 |
| NCT03152019 | Hospices Civils de Lyon | Hemorrhagic Hereditary Telangiectasia (HHT) | 2017-05-22 | PHASE2 |
| NCT00950391 | Washington University School of Medicine | Peripheral Nerve Injury | 2010-08 | PHASE1|PHASE2 |
| NCT06126380 | Eledon Pharmaceuticals | Kidney Transplant Rejection | 2023-10-25 | PHASE2 |
| NCT00144703 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital | Hematologic Malignancies|Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome|Non-Hodgkin´s Lymphoma|Hodgkin´s Disease | 2002-07 | PHASE2 |
| NCT00448201 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2011-01-07 | PHASE2 |
| NCT04022239 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Hematopoietic and Lymphoid System Neoplasm | 2020-03-13 | PHASE1|PHASE2 |
| NCT00896012 | University at Buffalo|Novartis|University of Washington | Kidney Transplantation | 2008-01 | PHASE4 |
| NCT04645667 | UNC Lineberger Comprehensive Cancer Center|University of North Carolina, Chapel Hill | Acute GVHD | 2021-02-01 | |
| NCT02582775 | Masonic Cancer Center, University of Minnesota | Epidermolysis Bullosa | 2016-03 | PHASE2 |
| NCT02453867 | Klemens Budde|Charite University, Berlin, Germany|European Renal Association - European Dialysis and Transplant Association|European Kidney Transplant Association (EKITA)|DESCARTES Working Group On Transplantation | Immunosuppression After Renal Transplantation | 2017-12 | PHASE4 |
| NCT00096096 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2004-08 | PHASE2 |
| NCT00136903 | Mesoblast, Inc. | Graft Vs Host Disease | 2005-04-27 | PHASE2 |
| NCT03066466 | Loyola University | Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome | 2019-12-10 | PHASE3 |
| NCT03042637 | Southeast Renal Research Institute | Nephrotic Syndrome | 2012-01 | |
| NCT05907746 | National Cancer Institute (NCI) | GATA2|Immunodeficiency | 2023-11-29 | PHASE2 |
| NCT00223054 | University Hospital Schleswig-Holstein|University of Kiel | Function of Renal Transplant | 2005-03 | |
| NCT03500848 | Southern Medical University, China|First Affiliated Hospital, Sun Yat-Sen University|Nanfang Hospital, Southern Medical University | Liver Transplantation | 2018-05-01 | PHASE2|PHASE3 |
| NCT02917096 | City of Hope Medical Center|National Cancer Institute (NCI) | Primary Myelofibrosis|Secondary Myelofibrosis | 2016-11-13 | PHASE1 |
| NCT07162896 | Shalamar Institute of Health Sciences | Atopic Dermatitis|Atopic Dermatitis (AD) | 2026-06 | PHASE3 |
| NCT04903054 | National Institute of Allergy and Infectious Diseases (NIAID)|Bristol-Myers Squibb|PPD Development, LP | Kidney Transplantation|Renal Transplant Recipients | 2022-01-10 | PHASE2 |
| NCT00670423 | Jennifer E. Schwartz|Millennium Pharmaceuticals, Inc. | Graft vs Host Disease|Peripheral Blood Stem Cell Transplantation|Transplantation, Homologous | 2008-05-16 | PHASE1 |
| NCT03959241 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI)|National Marrow Donor Program | Acute Leukemia|Chronic Myelogenous Leukemia (CML)|Myelodysplasia|Lymphoma | 2019-06-25 | PHASE3 |
| NCT01807767 | Medical College of Wisconsin | High Model for End-Stage Liver Disease (MELD) Score | 2013-03 | NA |
| NCT00643071 | Astellas Pharma Inc | Ulcerative Colitis | 2006-09 | PHASE3 |
| NCT00371319 | Tuen Mun Hospital | Lupus Nephritis | 2005-09 | PHASE4 |
| NCT05221411 | Leiden University Medical Center | Autoimmune Hepatitis | 2022-01-19 | PHASE4 |
| NCT04198506 | Philipps University Marburg | Transplantation Lung | 2020-08-05 | NA |
| NCT01935128 | University of Toledo Health Science Campus|Novartis Pharmaceuticals | Renal Transplant | 2013-07-03 | PHASE4 |
| NCT02159651 | Astellas Pharma Inc | Interstitial Pneumonia Associated With Polymyositis+Dermatomyositis | 2014-04-01 | |
| NCT07239128 | University of Seville|Centro Oculistico Borroni | Dry Eye Disease (DED) | 2024-05-01 | EARLY_PHASE1 |
| NCT00807144 | Imperial College Healthcare NHS Trust | End-stage Renal Failure|Graft Rejection | 2008-12 | PHASE4 |
| NCT01323920 | Dana-Farber Cancer Institute | Leukemia|Lymphoma|Myelodysplastic Syndrome | 2011-05 | PHASE2 |
| NCT00027573 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Kidney Cancer | 2001-10 | PHASE2 |
| NCT03047733 | Ajou University School of Medicine | Dermatologic Disease|Vitiligo | 2015-07-21 | NA |
| NCT01410747 | Astellas Pharma Inc | Lupus Nephritis | 2007-04-10 | |
| NCT01664910 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Hematopoietic and Lymphoid Cell Neoplasm | 2012-10-29 | PHASE1|PHASE2 |
| NCT02891603 | H. Lee Moffitt Cancer Center and Research Institute|CTI BioPharma|National Heart, Lung, and Blood Institute (NHLBI) | Graft Vs Host Disease|GVHD | 2017-06-08 | PHASE1|PHASE2 |
| NCT00134394 | University of Medicine and Dentistry of New Jersey | Psoriasis | 2005-02 | PHASE2 |
| NCT01027000 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Genentech, Inc.|Biologics, Inc. | Leukemia|Lymphoma | 2010-02 | PHASE2 |
| NCT00429416 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematologic Malignancies | 2004-03 | PHASE1|PHASE2 |
| NCT00789776 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|The Wayne D. Kuni and Joan E. Kuni Foundation | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Diffuse Large B-Cell Lymphoma|Previously Treated Myelodysplastic Syndrome|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Indolent Adult Non-Hodgkin Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Small Lymphocytic Lymphoma|Waldenstrom Macroglobulinemia | 2008-10-13 | PHASE1|PHASE2 |
| NCT01790594 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation|Rho Federal Systems Division, Inc.|Bristol-Myers Squibb | Simultaneous Kidney and Pancreas Transplantation | 2013-02 | PHASE2 |
| NCT03032783 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematopoietic and Lymphoid Cell Neoplasm | 2017-01-31 | PHASE2 |
| NCT04477629 | NYU Langone Health|Bristol-Myers Squibb | Heart Transplantation | 2020-08-06 | PHASE2 |
| NCT01390402 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Leukemia|Chronic Myelogenous Leukemia | 2012-01 | PHASE2 |
| NCT04207177 | Oslo University Hospital | Kidney Transplant; Complications|Immune Suppression | 2019-10-30 | PHASE4 |
| NCT07566377 | Memorial Sloan Kettering Cancer Center | Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Non-hodgkin Lymphoma|Hodgkin Lymphoma|Leukemia|Lymphoma|Graft-versus-host Disease | 2026-04-28 | PHASE2 |
| NCT01544842 | University of Oulu|Kuopio University Hospital | Oral Lichen Planus | 2004-08 | NA |
| NCT01132027 | Dr. Reddy´s Laboratories Limited | Healthy | 2008-01 | PHASE1 |
| NCT07548983 | OHSU Knight Cancer Institute|Incyte Corporation|Oregon Health and Science University | Acute Myeloid Leukemia | 2026-05-20 | PHASE1 |
| NCT04360031 | Université Catholique de Louvain | Kidney Transplant; Complications|Immunosuppression|Transplant Failure | 2020-02-10 | |
| NCT01309022 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Diabetes Mellitus, Type 1 | | |
| NCT00064701 | Astellas Pharma Inc | Kidney Transplantation | 2003-06 | PHASE3 |
| NCT00691262 | Astellas Pharma Inc | Dermatitis, Atopic | 2003-10 | PHASE3 |
| NCT05646992 | Johns Hopkins University | Uterine Factor Infertility | 2023-03-01 | PHASE2|PHASE3 |
| NCT00362531 | Peking University | Idiopathic Membranous Nephropathy|Nephrotic Syndrome | 2004-11 | PHASE2|PHASE3 |
| NCT06828796 | Northside Hospital, Inc. | Hematologic Disease and Disorders|Hematopoietic Cell Transplant | 2025-07-03 | PHASE2 |
| NCT01162005 | Seoul National University Hospital|Chong Kun Dang Pharmaceutical | Nephrotic Syndrome | 2010-07 | PHASE4 |
| NCT03099122 | Sanofi | End-stage Renal Disease | 2017-08-16 | PHASE4 |
| NCT00560378 | Astellas Pharma Inc | Dermatitis, Atopic|Eczema, Atopic | 1998-06 | PHASE3 |
| NCT05148715 | Université de Sherbrooke|McMaster University | Organ Transplant Failure or Rejection|Brain Death|Ischemic Reperfusion Injury | 2022-07-11 | PHASE2 |
| NCT05744635 | Chiesi Hungary Ltd.|Chiesi Slovenija, d.o.o. | Liver Failure | 2023-05-10 | |
| NCT03266393 | University of California, Los Angeles|Veloxis Pharmaceuticals | Kidney Transplantation|Renal Transplantation|Grafting, Kidney | 2019-01-15 | PHASE4 |
| NCT00134004 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2004-10 | PHASE2 |
| NCT00028171 | National Center for Research Resources (NCRR) | Kidney Transplantation | | NA |
| NCT04041219 | Mayo Clinic | Immunosuppression|Stem Cell Transplant|Bone Marrow Transplant | 2019-06-17 | PHASE4 |
| NCT01429844 | Universit?tsklinikum Hamburg-Eppendorf | Bronchiolitis Obliterans|Immunosuppression | 2001-01 | PHASE3 |
| NCT03882164 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Liver Transplant; Complications|Immunosuppression|Transplant Failure|Transplant; Complication, Rejection | 2019-02-21 | |
| NCT01116232 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2010-08 | PHASE2 |
| NCT04965597 | Fred Hutchinson Cancer Center|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI)|National Marrow Donor Program|National Heart, Lung, and Blood Institute (NHLBI) | Bone Marrow Failure Syndrome|Congenital Amegakaryocytic Thrombocytopenia|Diamond-Blackfan Anemia|Hereditary Sideroblastic Anemia|Paroxysmal Nocturnal Hemoglobinuria|Shwachman-Diamond Syndrome|Hematologic Neoplasm With Germline GATA2 Mutation|Hematologic Neoplasm With Germline SAMD9 Mutation|Hematologic Neoplasm With Germline SAMD9L Mutation | 2022-04-19 | PHASE2 |
| NCT03841097 | Roy D. Bloom, MD|Veloxis Pharmaceuticals | Kidney Transplant; Complications | 2019-11-11 | PHASE4 |
| NCT01080482 | Panacea Biotec Ltd | Healthy Volunteers | 2007-09 | NA |
| NCT00434811 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | 2006-10 | PHASE3 |
| NCT06291103 | University Hospital, Rouen | Kidney Transplant Rejection | 2026-03-01 | PHASE2|PHASE3 |
| NCT01875224 | University of Arizona|Bristol-Myers Squibb | New Onset Diabetes After Transplant|Kidney Transplantation | 2013-08 | PHASE4 |
| NCT04114097 | Jacob Thyssen|LEO Pharma | Atopic Dermatitis|Atopic Eczema | 2019-08-22 | PHASE4 |
| NCT02274662 | Sumitomo Pharma Switzerland GmbH | Poor Thymic Function|Immunodeficiency|Athymia|Immunoreconstitution|Thymus Transplantation|Low T Cell Numbers | 2014-08 | PHASE4 |
| NCT00717379 | Astellas Pharma Inc | Kidney Transplantation|Kidney Failure, Chronic|Renal Insufficiency, Chronic | 2007-05 | PHASE4 |
| NCT01532635 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Hematologic Malignancy|Leukemia|Acute Lymphoblastic Leukemia|ALL|Acute Myelogenous Leukemia|AML|Chronic Lymphocytic Leukemia|CLL|Lymphoma|Hodgkin´s Lymphoma|Non-hodgkin´s Lymphoma|Myeloma | 2012-03 | PHASE2 |
| NCT01509300 | Asan Medical Center | Acute Leukemia|Myelodysplastic Syndrome|Solid Tumors | 2012-01 | PHASE1|PHASE2 |
| NCT06035614 | Clarteis | Vitiligo|Pediatric ALL|Dermatologic Disease|Autoimmune Diseases | 2022-10-01 | NA |
| NCT00157014 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Heart Diseases|Heart Transplantation | 2004-05-10 | PHASE3 |
| NCT01707004 | University of Wisconsin, Madison|National Cancer Institute (NCI) | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia | 2013-05-16 | PHASE2 |
| NCT01005316 | National Institute of Allergy and Infectious Diseases (NIAID)|National Heart, Lung, and Blood Institute (NHLBI) | Pediatric Heart Transplantation|Pediatric Heart Transplant Recipients | 2010-01 | |
| NCT00555321 | Bristol-Myers Squibb | Immunosuppression in Solid Organ Transplant | 2008-01 | PHASE2 |
| NCT00038948 | Wyeth is now a wholly owned subsidiary of Pfizer | Renal Transplantation | 2002-01 | PHASE3 |
| NCT00556933 | University of Nebraska|Genzyme, a Sanofi Company | End-stage Renal Disease | 2004-04-01 | PHASE4 |
| NCT01652014 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2014-01 | PHASE2 |
| NCT04156204 | University of Colorado, Denver | Kidney Transplant Rejection|Medication Adherence | 2019-11-20 | EARLY_PHASE1 |
| NCT00189826 | Astellas Pharma Inc | Liver Transplantation | 2004-08 | PHASE3 |
| NCT00766909 | University of Aarhus | Complications of Transplanted Organs and Tissue|Diabetes Mellitus Nos New Onset | 2008-03 | PHASE4 |
| NCT00987103 | Maastricht University Medical Center | Organ Transplantation | 2009-09 | PHASE1 |
| NCT03249831 | City of Hope Medical Center|California Institute for Regenerative Medicine (CIRM) | Sickle Cell Disease|Sickle Cell Disorder|Hemoglobinopathies|Thalassemia|Anemia, Sickle Cell | 2019-01-04 | PHASE1 |
| NCT07214688 | Hackensack Meridian Health | Allogeneic Stem Cell Transplant Recipient | 2026-01-06 | PHASE2 |
| NCT00106639 | Pfizer | Kidney Transplantation | 2005-05 | PHASE2 |
| NCT00182559 | Medical University of Vienna | End Stage Renal Disease | 2004-04 | PHASE4 |
| NCT02833805 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Severe Aplastic Anemia|Aplastic Anemia|Bone Marrow Failure|Immunosuppression | 2016-09 | PHASE2 |
| NCT01068067 | Sun Yat-sen University|First Affiliated Hospital, Sun Yat-Sen University | Renal Transplantation | 2010-03 | NA |
| NCT07367932 | Cairo University | Dermatitis, Atopic|Eczema | 2026-02 | PHASE4 |
| NCT00146614 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Beth Israel Deaconess Medical Center|Massachusetts General Hospital | Graft Versus Host Disease|Hematologic Malignancies | 2002-07 | PHASE2 |
| NCT01288521 | Sony Tuteja|American College of Clinical Pharmacy | Kidney Transplantation | 2008-10 | PHASE4 |
| NCT00109993 | Case Comprehensive Cancer Center|National Cancer Institute (NCI) | Breast Cancer|Chronic Myeloproliferative Disorders|Gestational Trophoblastic Tumor|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases|Neuroblastoma|Ovarian Cancer|Testicular Germ Cell Tumor | 2005-01 | PHASE2 |
| NCT05396898 | University Hospital Tuebingen | Posttransplant Diabetes Mellitus | 2020-12-16 | PHASE4 |
| NCT00322101 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Acute Myeloid Leukemia+Transient Myeloproliferative Disorder|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2006-01 | PHASE3 |
| NCT00147381 | Dr. Claudia B?smüller|Astellas Pharma GmbH | Kidney Transplantation | 2004-01 | PHASE3 |
| NCT00203281 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Kidney Transplantation|Plasmapheresis | 2003-02 | |
| NCT00881556 | Columbia University | Epidermolysis Bullosa | 2009-08-20 | EARLY_PHASE1 |
| NCT00302536 | Nanjing University School of Medicine | Focal Glomerulosclerosis | 2006-03 | NA |
| NCT04262843 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|High Risk Myelodysplastic Syndrome|Myelodysplastic Syndrome | 2020-02-07 | PHASE2 |
| NCT01998789 | Tomoaki Kato | Orthotopic Liver Transplant | 2013-10 | PHASE2 |
| NCT00637143 | Astellas Pharma Inc|Astellas Pharma Canada, Inc. | Renal Transplantation|Chronic Renal Allograft Failure | 1999-04 | PHASE4 |
| NCT02213068 | Lorenzo Gallon|Bristol-Myers Squibb | Transplant; Failure, Kidney|EBV | 2014-07 | PHASE4 |
| NCT00236106 | Children?s Clinic, Randers | Atopic Dermatitis | 2005-02 | PHASE4 |
| NCT03388008 | Washington University School of Medicine|National Heart, Lung, and Blood Institute (NHLBI)|Bristol-Myers Squibb | Lung Transplant Rejection|Antibody-mediated Rejection | 2019-12-17 | PHASE2 |
| NCT03527238 | University of Florida|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Liver Transplant|Kidney Transplant | 2018-09-21 | PHASE2 |
| NCT04177004 | City of Hope Medical Center|National Cancer Institute (NCI) | Allogeneic Hematopoietic Stem Cell Transplant Recipient|Hematopoietic and Lymphoid Cell Neoplasm | 2021-04-30 | PHASE1 |
| NCT01760655 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Acute Myeloid Leukemia With FLT3+ITD Mutation|Acute Myeloid Leukemia With Gene Mutations|Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM|Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214|Aplastic Anemia|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Follicular Lymphoma|Hodgkin Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Myeloid Leukemia|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|Polycythemia Vera|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia | 2012-12-24 | PHASE2 |
| NCT04009525 | First Affiliated Hospital of Guangxi Medical University|Peking University People´s Hospital|Ruijin Hospital|The 923rd Hospital of Joint Logistics Support Force of People´s Liberation Army|LiuZhou People´s Hospital|The First People´s Hospital of Yunnan|Liuzhou Workers´ Hospital|Xinqiao Hospital of Chongqing|Affiliated Hospital of Youjiang University of Ethnic Medicine|Hainan People´s Hospital|Maoming People´s Hospital|Red Cross Hospital of Yulin City|Guilin Medical College|Wuzhou People´s Hospital|Guangxi Autonomous Region People´s Hospital|The 920th Hospital of Joint Logistics Support Force of People´s Liberation Army | Thalassemia Major | 2019-07-05 | PHASE4 |
| NCT01371344 | Astellas Pharma Europe Ltd. | Heart Transplantation|Kidney Transplantation|Liver Transplantation | 2011-06-24 | PHASE4 |
| NCT02446964 | City of Hope Medical Center|National Cancer Institute (NCI) | Adult Acute Lymphoblastic Leukemia in Complete Remission|Acute Myeloid Leukemia in Remission|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Childhood Acute Lymphoblastic Leukemia in Complete Remission | 2015-06-25 | PHASE1 |
| NCT00972101 | M.D. Anderson Cancer Center | Stem Cell Transplantation|Leukemia|Lymphoma|Pediatric Disorders | 2009-09 | PHASE1 |
| NCT02199041 | St. Jude Children´s Research Hospital | Hematological Malignancies | 2014-07-11 | PHASE2 |
| NCT03540472 | Peking Union Medical College Hospital | Pure Red Cell Aplasia | 2018-06-10 | PHASE4 |
| NCT00296296 | Stanford University | Kidney Transplant|Diabetes Mellitus, Type 2|Diabetic Nephropathy | 2005-06 | PHASE4 |
| NCT01168219 | National Cancer Institute (NCI) | Acute Myeloid Leukemia|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts|Recurrent Adult Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome | 2010-07-15 | PHASE2 |
| NCT00014911 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Diabetes Mellitus, Insulin-Dependent | 2001-04 | PHASE2 |
| NCT01289301 | Hannover Medical School | Disorder Related to Renal Transplantation|Immunosuppression Related Infectious Disease|Virus Diseases | 2011-10 | PHASE4 |
| NCT00025519 | Fox Chase Cancer Center|National Cancer Institute (NCI) | Kidney Cancer | 2001-06 | PHASE2 |
| NCT00160966 | University of Giessen|Heidelberg University|Hoffmann-La Roche|Astellas Pharma Inc|Novartis | Polyomavirus Infections | 2004-09 | PHASE4 |
| NCT01797341 | University Health Network, Toronto | Kidney-Pancreas Transplantation | 2013-06 | PHASE3 |
| NCT02077556 | National Taiwan University Hospital | Drug Interaction Potentiation | 2014-04 | PHASE4 |
| NCT00002792 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Myelodysplastic+Myeloproliferative Diseases | 1996-06 | PHASE2 |
| NCT01471444 | M.D. Anderson Cancer Center|Sanofi | Disorder Related to Bone Marrow Transplantation|Leukemia|Transplantation Infection | 2011-11-02 | PHASE3 |
| NCT06265584 | University of Alabama at Birmingham | Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Disorders | 2025-04-08 | PHASE2 |
| NCT01060475 | Limerick BioPharma | Healthy | 2010-02 | PHASE1 |
| NCT00439556 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | CD20 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Lymphocytic Neoplasm|Lymphoma | 2007-02-13 | PHASE2 |
| NCT03713645 | Temple University|Veloxis Pharmaceuticals | Kidney Transplant | 2018-11-12 | PHASE4 |
| NCT01207297 | Zhejiang University | SLE|Lupus Nephritis|Renal Insufficiency|End-stage Renal Disease | 2003-03 | PHASE1 |
| NCT05501574 | TFF Pharmaceuticals, Inc.|Novotech (Australia) Pty Limited | Lung Transplant Rejection | 2023-04-18 | PHASE2 |
| NCT06195891 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndrome | 2024-05-24 | PHASE1 |
| NCT00043979 | National Cancer Institute (NCI) | Sarcoma | 2002-09-19 | PHASE2 |
| NCT00260208 | Novartis Pharmaceuticals | Liver Transplant|Hepatitis C | 2006-01 | PHASE4 |
| NCT00912678 | University of Luebeck|Astellas Pharma GmbH | Kidney Transplantation | 2002-03 | PHASE4 |
| NCT00117689 | Genzyme, a Sanofi Company | Liver Dysfunction|Rejection, Transplant|Transplantation, Liver | 2005-04 | PHASE2 |
| NCT03644485 | Astellas Pharma China, Inc. | Kidney Transplant | 2018-10-21 | PHASE4 |
| NCT00275535 | Mayo Clinic|Wyeth is now a wholly owned subsidiary of Pfizer|Genzyme, a Sanofi Company|Roche Pharma AG | Kidney Diseases | 2001-04 | PHASE4 |
| NCT02652468 | University of Wisconsin, Madison | Lymphoma | 2016-03-10 | NA |
| NCT06307808 | University Hospital, Grenoble|National Agency for Research on AIDS and Viral Hepatitis (ANRS) | HBV|Kidney Transplantation|Liver Transplantation | 2024-03-15 | |
| NCT03121014 | University of Illinois at Chicago | Acute Myeloid Leukemia|Myelodysplastic Syndromes | 2017-04-24 | PHASE2 |
| NCT02061800 | Diane George | Chronic Myeloid Leukemia (CML)|Acute Myelogenous Leukemia (AML)|Myelodysplastic Syndrome (MDS)|Juvenile Myelomonocytic Leukemia (JMML)|Acute Lymphoblastic Leukemia (ALL)|Lymphoma (Hodgkin´s and Non-Hodgkin´s) | 2013-06-03 | PHASE1|PHASE2 |
| NCT00406393 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI) | Leukemia, Myelocytic, Acute|Leukemia, Lymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes | 2006-11 | PHASE3 |
| NCT04063865 | Indiana University | Kidney Failure | 2019-05-09 | PHASE3 |
| NCT06183892 | RenJi Hospital | Liver Transplant | 2024-03-04 | NA |
| NCT03864926 | University of Wisconsin, Madison|Veloxis Pharmaceuticals | Delayed Graft Function | 2019-03-18 | PHASE4 |
| NCT00402558 | M.D. Anderson Cancer Center | Myelodysplastic Syndrome|Leukemia | 2006-05 | PHASE1 |
| NCT06692426 | Masonic Cancer Center, University of Minnesota|Duchenne UK|Parent Project Muscular Dystrophy | Duchenne Muscular Dystrophy | 2025-03-20 | PHASE1 |
| NCT00282243 | Astellas Pharma Inc | Liver Transplantation | 2003-02 | PHASE2 |
| NCT00555048 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2007-09 | PHASE1|PHASE2 |
| NCT01055964 | Seoul National University Hospital | Pharmacokinetics|Tacrolimus | 2008-09 | PHASE3 |
| NCT04045171 | The Third Xiangya Hospital of Central South University|Hunan Provincial People´s Hospital|ZhuZhou Central Hospital|First People´s Hospital of Chenzhou | Nephrotic Syndrome|Tacrolimus|Pharmacokinetics | 2019-08-10 | |
| NCT00843856 | Imperial College Healthcare NHS Trust | Glomerulonephritis, Membranous | 2009-03-03 | PHASE4 |
| NCT01325571 | Astellas Pharma Inc|Astellas Pharma China, Inc. | Myasthenia Gravis | 2011-03 | PHASE3 |
| NCT02178683 | Colorado Blood Cancer Institute | Graft Versus Host Disease | 2010-11 | PHASE3 |
| NCT02373202 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2015-02 | PHASE3 |
| NCT01044745 | University of Nebraska|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Graft Versus Host Disease|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia+Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Mycosis Fungoides+Sezary Syndrome|Stage I Small Lymphocytic Lymphoma|Stage II Adult T-cell Leukemia+Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Mycosis Fungoides+Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia+Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides+Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides+Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Waldenstr?m Macroglobulinemia | 2009-12-10 | PHASE2 |
| NCT02545972 | Newark Beth Israel Medical Center | Heart Failure | 2016-02 | PHASE4 |
| NCT02152345 | Columbia University | Implant or Graft; Rejection | 2014-06 | PHASE4 |
| NCT02456025 | The Eye Center and The Eye Foundation for Research in Ophthalmology | Vernal Keratoconjunctivitis | 2013-04 | PHASE4 |
| NCT00874315 | Nationwide Children´s Hospital | Neuroblastoma | 2008-09 | PHASE2 |
| NCT01160276 | Assistance Publique - H?pitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France | Renal Replacement Therapies | 2010-05 | PHASE1 |
| NCT02601703 | Glenmark Pharmaceuticals Ltd. India | Atopic Dermatitis | 2015-08 | PHASE3 |
| NCT03511560 | Columbia University|Veloxis Pharmaceuticals | Renal Transplant Rejection|Kidney Transplant Failure and Rejection | 2018-07-26 | PHASE4 |
| NCT06701825 | Instituto de Investigación Hospital Universitario La Paz|Instituto de Salud Carlos III | Kidney Disease, Chronic|Transplant Recipient (Kidney)|Immunosuppression | 2025-06-02 | PHASE4 |
| NCT02921789 | Astellas Pharma Global Development, Inc.|Kyowa Kirin Co., Ltd. | Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS) | 2017-05-22 | PHASE2 |
| NCT00564538 | University of Nebraska|Genzyme, a Sanofi Company | Liver Transplantation|Liver Disease|Immunosuppression | 2007-12 | PHASE4 |
| NCT00650468 | Astellas Pharma Inc | Renal Transplantation | 1999-11 | PHASE4 |
| NCT06203470 | Assiut University | Psoriasis Vulgaris | 2024-06 | PHASE4 |
| NCT01659606 | Boston Children´s Hospital|Dana-Farber Cancer Institute|Children´s Hospital Medical Center, Cincinnati|Fred Hutch+University of Washington+Seattle Children´s Cancer Consortium|Baylor College of Medicine|Children´s Hospital of Philadelphia|University of Wisconsin, Madison|Karolinska University Hospital|Hackensack Meridian Health|Oslo University Hospital|Children´s Mercy Hospital Kansas City|University of Chicago|Massachusetts General Hospital | Dyskeratosis Congenita|Hoyeraal Hreidarsson Syndrome|Revesz Syndrome|Aplastic Anemia | 2012-07 | PHASE2 |
| NCT01203722 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Hematologic Malignancies | 2010-09 | PHASE1|PHASE2 |
| NCT02080195 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Maryland Stem Cell Research Fund | Lupus Erythematosus|Graft-versus-host Disease | 2016-09-13 | PHASE1|PHASE2 |
| NCT00429377 | Astellas Pharma Inc | Lupus Nephritis | 2003-06 | PHASE3 |
| NCT01551212 | Novartis Pharmaceuticals | Liver Transplantation | 2012-05-24 | PHASE4 |
| NCT01764581 | University of Bologna | Liver Disease | 2008-07 | NA |
| NCT05027945 | National Cancer Institute (NCI) | Immunodeficiency|Hematopoietic Stem Cell Transplantation | 2023-02-23 | PHASE2 |
| NCT00374231 | University of Cincinnati|Astellas Pharma Inc | Liver Transplantation | 2002-10 | PHASE4 |
| NCT00384202 | Astellas Pharma Inc | Transplantation | 2006-10 | PHASE3 |
| NCT02723786 | GlaxoSmithKline | Kidney Transplantation (Status Post) | 2016-08-27 | PHASE2 |
| NCT00469131 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan|Kyoto University | Hepatitis C|Liver Cirrhosis | 2003-09 | PHASE3 |
| NCT00298662 | Clinique de sclérose en plaques et neuromusculaire de l´Outaouais | Multiple Sclerosis | 2003-02 | PHASE2 |
| NCT00693446 | Nantes University Hospital | Pancreas Transplantation|Kidney Transplantation | 2004-04 | PHASE4 |
| NCT07412470 | Sanofi | Kidney Transplant Rejection | 2026-03-13 | PHASE2|PHASE3 |
| NCT04904588 | Center for International Blood and Marrow Transplant Research|National Marrow Donor Program | Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Mixed Phenotype Acute Leukemia|Acute Leukemia|Myelodysplastic Syndromes|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Lymphoma | 2021-09-30 | PHASE2 |
| NCT00812786 | University Hospital, Limoges | Heart Transplant | 2007-07 | PHASE4 |
| NCT03465969 | Astellas Pharma Europe Ltd. | Kidney Transplantation|Liver Transplantation | 2018-03-20 | PHASE4 |
| NCT00789308 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium | Diabetes Mellitus, Type I | 2008-07-11 | PHASE2 |
| NCT00914940 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes | 2009-12-17 | PHASE2 |
| NCT00480896 | Astellas Pharma Inc | Dermatitis, Atopic | 2004-06 | PHASE3 |
| NCT07359859 | Memorial Sloan Kettering Cancer Center|Incyte Corporation | Hematologic Malignancies | 2026-01-20 | PHASE2 |
| NCT04237246 | University of Manitoba | Liver Failure | 2015-04 | PHASE4 |
| NCT00002809 | Temple University | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 1996-08 | PHASE2 |
| NCT03751332 | Medical University of Vienna | Immunosuppression|Renal Failure | 2008-03 | PHASE4 |
| NCT03095547 | F2G Biotech GmbH|Bio-Kinetic Europe, Ltd. | Invasive Aspergillosis | 2017-05 | PHASE1 |
| NCT00446264 | University Hospital, Lille|Institut National de la Santé Et de la Recherche Médicale, France | Type 1 Diabetes|Hypoglycemia|Metabolic Diseases | 2003-05 | PHASE2 |
| NCT03715387 | University of British Columbia | Edema Face | 2018-10-10 | PHASE2|PHASE3 |
| NCT02081755 | Baylor Research Institute | Carcinoma, Hepatocellular | 2014-03 | PHASE4 |
| NCT05156710 | Sanofi | Transplant Rejection | 2022-06-09 | PHASE2 |
| NCT01246206 | Barbara Ann Karmanos Cancer Institute | Hematological Malignancies | 2010-11 | PHASE2 |
| NCT01446484 | Pirogov Russian National Research Medical University|Russian Academy of Medical Sciences | End-Stage Renal Disease|Kidney Failure | 2011-10 | PHASE1|PHASE2 |
| NCT00518271 | Wyeth is now a wholly owned subsidiary of Pfizer | Kidney Transplantation | 2000-04 | PHASE2 |
| NCT02377609 | Astellas Pharma Europe Ltd. | Validation|Dried Blood Spot|Transplant Patients | 2013-10 | |
| NCT05293509 | M.D. Anderson Cancer Center | Stem Cell Transplantation | 2022-03-02 | PHASE2 |
| NCT00299221 | Newark Beth Israel Medical Center|Astellas Pharma Inc | Immunosuppression | 2004-04 | PHASE4 |
| NCT05089604 | University of British Columbia|Paladin Labs Inc. | Liver Transplantation|Immunosuppression|Neurotoxicity|Tremor|Tacrolimus | 2023-01-09 | PHASE4 |
| NCT04220008 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent Aggressive Non-Hodgkin Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Burkitt Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent High Grade B-Cell Lymphoma|Recurrent T-Cell Non-Hodgkin Lymphoma|Recurrent Transformed B-Cell Non-Hodgkin Lymphoma | 2021-10-29 | PHASE2 |
| NCT06859424 | Center for International Blood and Marrow Transplant Research|National Marrow Donor Program|Incyte Corporation | AML (Acute Myelogenous Leukemia)|Acute Lymphoid Leukemia (ALL)|Acute Leukemia (Category)|MDS (Myelodysplastic Syndrome)|CML (Chronic Myelogenous Leukemia)|CLL (Chronic Lymphocytic Leukemia)|Prolymphocyctic Leukemia|Chronic Myelomonocytic Leukemia (CMML)|Myeloproliferative Neoplasm (MPN)|Lymphoma|Myelofibrosis | 2025-07-25 | PHASE2 |
| NCT00005113 | Boston Children´s Hospital | End-Stage Renal Disease|Kidney Transplantation | 1999-07 | PHASE3 |
| NCT00293891 | Astellas Pharma Inc|Astellas Pharma US, Inc. | Psoriasis | | PHASE3 |
| NCT01789255 | National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Grade III Lymphomatoid Granulomatosis|B-cell Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Graft Versus Host Disease|Intraocular Lymphoma|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Post-transplant Lymphoproliferative Disorder|Primary Central Nervous System Hodgkin Lymphoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Ringed Sideroblasts|Refractory Chronic Lymphocytic Leukemia|Refractory Cytopenia With Multilineage Dysplasia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Central Nervous System Hodgkin Lymphoma|Secondary Central Nervous System Non-Hodgkin Lymphoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Hodgkin Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Small Lymphocytic Lymphoma|Stage II Adult Hodgkin Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Testicular Lymphoma|Waldenstr?m Macroglobulinemia | 2013-06 | PHASE2 |
| NCT00513474 | Massachusetts General Hospital | Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2008-01 | PHASE1 |
| NCT02909335 | Rennes University Hospital | Liver Transplantation | 2016-11 | PHASE3 |
| NCT03225417 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla|Spanish Clinical Research Network - SCReN | Hematopoietic Stem Cell Transplantation|Multiple Myeloma | 2017-05-16 | PHASE1|PHASE2 |
| NCT01388517 | Universidad Autonoma de San Luis Potosí|Hospital Central "Dr. Ignacio Morones Prieto" | Pityriasis Alba | 2008-01 | PHASE4 |
| NCT00295607 | Astellas Pharma Inc | Hepatitis C|Liver Transplantation | 2005-06 | PHASE2 |
| NCT01629511 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Richter Syndrome | 2012-11-21 | PHASE1|PHASE2 |
| NCT00087581 | Hoffmann-La Roche | Kidney Transplantation | 2004-06 | PHASE4 |
| NCT02122081 | Sumithira Vasu | Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia | 2015-07-27 | PHASE1 |
| NCT00790439 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type I | 2008-07 | PHASE2 |
| NCT07532330 | Minia University | Vitiligo | 2025-08-01 | NA |
| NCT00282256 | Astellas Pharma Inc | Liver Transplantation | 2004-01 | PHASE2 |
| NCT01479881 | Tibotec Pharmaceuticals, Ireland | Hepatitis C Virus | 2011-10 | PHASE1 |
| NCT01856257 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Primary Renal Allograft Candidate|Kidney Transplantation | 2013-07 | PHASE2 |
| NCT00275509 | Johns Hopkins University | Kidney Failure, Chronic | 2007-01 | PHASE3 |
| NCT03380936 | University of Colorado, Denver|Veloxis Pharmaceuticals | Kidney Transplant Rejection | 2018-01-17 | EARLY_PHASE1 |
| NCT03770663 | Assistance Publique - H?pitaux de Paris | Antisynthetase Syndrome (ASS)|Interstitial Lung Disease | 2021-02-05 | PHASE3 |
| NCT00621699 | University Medicine Greifswald | Pharmacokinetics|Drug Interactions|Hypercholesterolemia|Immunosuppression | 2007-09 | PHASE1 |
| NCT00935298 | The Second Artillery General Hospital|Capital Medical University|Shanghai Changzheng Hospital|Pharmacology Research Institute|Air Force General Hospital of the PLA|Health Department of General Logistics | Renal Transplantation | 2009-07 | PHASE4 |
| NCT01875237 | M.D. Anderson Cancer Center|Bellicum Pharmaceuticals | Leukemia|Myeloma|Myeloproliferative Diseases | 2013-12-27 | PHASE1|PHASE2 |
| NCT01488253 | The Korean Society of Blood and Marrow Transplantation|Asan Medical Center|Chonbuk National University Hospital|Chonnam National University Hospital|Chung-Ang University Hosptial, Chung-Ang University College of Medicine|Daegu Catholic University Medical Center|Ewha Womans University Mokdong Hospital|Gachon University Gil Medical Center|Inha University Hospital|Inje University|Keimyung University Dongsan Medical Center|Korea University Anam Hospital|Pusan National University Hospital|Samsung Medical Center|Severance Hospital|Seoul St. Mary´s Hospital|Seoul National University Hospital|Soonchunhyang University Hospital | Acute Leukemia in Remission|Myelodysplastic Syndromes|Leukemia, Myeloid, Chronic-Phase|Leukemia, Myeloid, Accelerated-Phase | 2012-01 | PHASE2 |
| NCT03386305 | Albert Einstein Healthcare Network|Veloxis Pharmaceuticals | Post Liver Transplant | 2017-12-13 | PHASE2|PHASE3 |
| NCT05577637 | Combined Military Hospital Abbottabad | Vitiligo | 2021-05-01 | PHASE1 |
| NCT04498741 | Enanta Pharmaceuticals, Inc|Pharmaceutical Research Associates | RSV Infection | 2020-07-08 | PHASE1 |
| NCT01871441 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Malignant Neoplasm | 2013-05-17 | PHASE2 |
| NCT00296023 | University of California, San Francisco|National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1999-01 | NA |
| NCT07138742 | Sohag University | Vernal Keratoconjunctivitis | 2025-09 | NA |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT03626714 | Auritec Pharmaceuticals|National Institute of Allergy and Infectious Diseases (NIAID) | Organ Transplant Rejection|Psoriasis | 2018-10-16 | EARLY_PHASE1 |
| NCT02057484 | Astellas Pharma Europe Ltd. | Liver Transplant|Kidney Transplant | 2014-03-03 | |
| NCT00821587 | University of Florida|Novartis Pharmaceuticals | Hepatitis C | 2004-06 | PHASE4 |
| NCT04530487 | M.D. Anderson Cancer Center | Desmoplastic Small Round Cell Tumor|Ewing Sarcoma+Peripheral Primitive Neuroectodermal Tumor|Recurrent Desmoplastic Small Round Cell Tumor|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Neuroblastoma|Recurrent Rhabdomyosarcoma|Refractory Desmoplastic Small Round Cell Tumor|Refractory Malignant Peripheral Nerve Sheath Tumor|Refractory Malignant Solid Neoplasm|Refractory Neuroblastoma|Refractory Rhabdomyosarcoma | 2020-08-19 | PHASE2 |
| NCT06591884 | Hospital de Clinicas de Porto Alegre | Oral Erosive Lichen Planus | 2024-09-03 | PHASE1|PHASE2 |
| NCT00325325 | Hospital Universitario Ramon y Cajal|Novartis|Astellas Pharma Inc | Kidney Diseases | 2006-01 | PHASE2 |
| NCT00282282 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital | Graft Versus Host Disease|GVHD | 2006-01 | PHASE2 |
| NCT02084446 | Ronaldo de Matos Esmeraldo, MD|Novartis Pharmaceuticals | Transplantation Infection|Cytomegalovirus Infections | 2012-12 | PHASE4 |
| NCT00560326 | Astellas Pharma Inc | Dermatitis, Atopic | 2003-06 | PHASE2 |
| NCT00304720 | Colorado Blood Cancer Institute | Multiple Myeloma|Lymphoma|Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome | 2004-03 | PHASE2 |
| NCT07519174 | Foundation University Islamabad|Fauji Foundation Hospital | Atopic Dermatitis | 2026-06-01 | NA |
| NCT05490511 | Indiana University|National Center for Complementary and Integrative Health (NCCIH) | CBD|Transplant Complication|Kidney Disease, Chronic | 2022-10-31 | PHASE1 |
| NCT00003572 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1998-08 | PHASE2 |
| NCT02294552 | Ivan S Moiseev | Acute Myeloid Leukemia|Acute Lymphoid Leukemia|Lymphoma|Myelodysplastic Syndromes|Chronic Lymphocytic Leukemia|Immune System Diseases | 2014-10 | PHASE2 |
| NCT01653847 | Northwestern University|Novartis | End Stage Renal Failure With Renal Transplant | 2013-02 | NA |
| NCT04542733 | King Chulalongkorn Memorial Hospital | Kidney Transplant Infection|BK Virus Infection | 2021-02-10 | NA |
| NCT02217410 | Novartis Pharmaceuticals | Kidney Transplantation | 2015-02-05 | PHASE1|PHASE2 |
| NCT02130817 | University of Wisconsin, Madison|Bristol-Myers Squibb | End Stage Renal Disease|Antibody Mediated Rejection | 2014-09-24 | PHASE4 |
| NCT00669890 | New York Medical College | Acute Myeloid Leukemia|Juvenile Myelomonocytic Leukemia|Myelodysplastic Syndrome | 2004-05 | PHASE1 |
| NCT00423826 | Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous Condition|Secondary Myelofibrosis | 2007-01 | |
| NCT02438982 | Nilratan Sircar Medical College | Nephrotic Syndrome | 2015-05-08 | PHASE3 |
| NCT01888432 | Novartis Pharmaceuticals | Liver Transplantation | 2013-09-25 | PHASE3 |
| NCT01154387 | Tolera Therapeutics, Inc | End Stage Renal Disease|Renal Transplant | 2010-07 | PHASE1|PHASE2 |
| NCT03760263 | Sentara Norfolk General Hospital|Veloxis Pharmaceuticals | Transplant;Failure,Kidney | 2020-01-16 | PHASE4 |
| NCT00434850 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type 1 | 2006-10 | PHASE2 |
| NCT06055608 | National Institute of Allergy and Infectious Diseases (NIAID) | Kidney Transplant | 2024-05-22 | PHASE2 |
| NCT02711826 | National Institute of Allergy and Infectious Diseases (NIAID)|Clinical Trials in Organ Transplantation | Kidney Transplant|Adult Living Donor Kidney Transplant Recipients|Renal Transplant|Living Kidney Donor | 2016-09-20 | PHASE1|PHASE2 |
| NCT02799888 | Affiliated Hospital to Academy of Military Medical Sciences | Graft-versus-host Disease|Hematopoietic Stem Cell Transplantation | 2014-04 | PHASE2 |
| NCT00946023 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Lymphoma|B-cell Lymphoma|Non Hodgkin Lymphoma|Chronic Lymphocytic Leukemia | 2009-07 | PHASE2 |
| NCT00369161 | Novartis | Renal Transplantation | 2006-06 | PHASE4 |
| NCT03978494 | Sandoz | Kidney Transplant | 2019-09-02 | PHASE1 |
| NCT03535051 | Kasr El Aini Hospital | Stable Vitiligo | 2015-01-01 | NA |
| NCT00629122 | Weill Medical College of Cornell University | Kidney Failure, Chronic | 2008-02 | PHASE4 |
| NCT06348602 | Hospital Universitario Dr. Jose E. Gonzalez | Ocular Graft-versus-host Disease | 2023-08-01 | PHASE1|PHASE2 |
| NCT04263519 | Massachusetts General Hospital | Alzheimer Disease|Mild Cognitive Impairment | 2021-12-01 | PHASE2 |
| NCT01384513 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK+T-cell Lymphoma|Aplastic Anemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Essential Thrombocythemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Juvenile Myelomonocytic Leukemia|Mastocytosis|Myelodysplastic+Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Polycythemia Vera|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstr?m Macroglobulinemia | 2011-08-04 | PHASE2 |
| NCT00382109 | Children´s Oncology Group|National Cancer Institute (NCI) | B-cell Childhood Acute Lymphoblastic Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Graft Versus Host Disease|L1 Childhood Acute Lymphoblastic Leukemia|L2 Childhood Acute Lymphoblastic Leukemia|T-cell Childhood Acute Lymphoblastic Leukemia | 2007-03 | PHASE3 |
| NCT00296309 | Astellas Pharma Inc|Astellas Pharma Europe B.V. | Kidney Transplantation | 2004-10 | PHASE3 |
| NCT00498316 | M.D. Anderson Cancer Center|ViaCell|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Myelodysplastic Syndrome|Leukemia | 2007-07-03 | PHASE1 |
| NCT07203664 | Hospital Universitario La Paz | Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients | 2025-10-30 | PHASE4 |
| NCT00622895 | Fred Hutchinson Cancer Center|National Institute of Allergy and Infectious Diseases (NIAID) | Systemic Scleroderma|Severe Systemic Sclerosis | 2006-09-01 | PHASE1|PHASE2 |
| NCT01884571 | Emory University|ALS Association | Amyotrophic Lateral Sclerosis (ALS) | 2013-10 | PHASE2 |
| NCT00166712 | Northwestern University|Roche Pharma AG | Kidney Transplant Failure and Rejection | 2005-04 | PHASE4 |
| NCT04701528 | Leiden University Medical Center|Aurinia Pharmaceuticals Inc. | Covid19|Kidney Transplant Infection | 2020-11-15 | PHASE2 |
| NCT01294020 | Astellas Pharma Europe Ltd. | Intestine Transplantation|Kidney Transplantation|Lung Transplantation|Liver Transplantation|Heart Transplantation | 2011-05-25 | PHASE2 |
| NCT00309101 | Astellas Pharma Inc | Myasthenia Gravis | 2006-02 | PHASE3 |
| NCT00297310 | Janssen-Cilag Pty Ltd | Kidney Transplantation|Transplantation | 2004-05 | PHASE4 |
| NCT00857389 | M.D. Anderson Cancer Center | Stem Cell Transplantation|Leukemia|Lymphoma | 2009-03-02 | PHASE2 |
| NCT04440371 | Jordan University of Science and Technology | Vitiligo, Generalized | 2020-06-21 | NA |
| NCT02587052 | Vastra Gotaland Region | Renal Transplantation | 2015-10 | |
| NCT05115630 | M.D. Anderson Cancer Center | Myeloid Malignancies|Acute Myeloid Leukemia|Myelodysplastic Syndrome|Chronic Myeloid Leukemia | 2022-04-08 | PHASE2 |
| NCT01224028 | Astellas Pharma Inc|Astellas Pharma Korea, Inc. | IgA Nephropathy | 2010-11 | PHASE2 |
| NCT02342145 | Zhongming Zhang|Liuzhou Workers´ Hospital|Hainan General Hospital|McMaster University|Guangxi Key Laboratory of Thalassemia Research|NHC Key Laboratory of Thalassemia Medicine | Beta-Thalassemia Major|Graft-versus-host Disease (GVHD) | 2015-04 | PHASE4 |
| NCT03645057 | University of Rochester | Atopic Dermatitis | 2019-02-20 | PHASE3 |
| NCT05916781 | Chinese SLE Treatment And Research Group|Peking Union Medical College Hospital | Systemic Lupus Erythematosus|Lupus Nephritis | 2023-07-01 | PHASE4 |
| NCT04370301 | Fred Hutchinson Cancer Center | Primary Myelofibrosis|Secondary Myelofibrosis | 2021-02-09 | PHASE2 |
| NCT01068054 | Siriraj Hospital | Keratoconjunctivitis, Vernal | 2003-06 | PHASE2|PHASE3 |
| NCT02208037 | National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI) | Acute Leukemia|Chronic Myelogenous Leukemia|Myelodysplasia|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse|Hodgkin´s Lymphoma | 2014-08 | PHASE2 |
| NCT00301951 | University of California, San Francisco|National Cancer Institute (NCI) | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2004-09 | PHASE1 |
| NCT01371331 | Astellas Pharma Europe Ltd. | Kidney Transplantation|Heart Transplantation|Liver Transplantation | 2011-06-09 | PHASE4 |
| NCT02068170 | KU Leuven|Agentschap voor Innovatie door Wetenschap en Technologie | Delirium|QT-prolongation | 2014-02 | |
| NCT00938860 | Novartis Pharmaceuticals | Hepatitis C|Liver Transplantation | 2009-09 | PHASE4 |
| NCT01010217 | M.D. Anderson Cancer Center | Blood Stem Cell Transplant Failure|Leukemia|Hematologic Malignancies | 2009-11-05 | PHASE2 |
| NCT02014103 | University of Cincinnati|University of Colorado, Denver|Children´s Hospital Medical Center, Cincinnati | Complication of Transplant | 2015-03 | PHASE4 |
| NCT03413722 | University of Kansas Medical Center|Novartis Pharmaceuticals | End Stage Renal Disease | 2018-02-01 | |
| NCT00404794 | Hospital Authority, Hong Kong|The University of Hong Kong | Lupus Nephritis|Glomerulonephritis, Membranous | 2005-11 | PHASE3 |
| NCT03426969 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Primary Myelofibrosis|Secondary Myelofibrosis | 2018-01-31 | EARLY_PHASE1 |
| NCT00720629 | H. Lee Moffitt Cancer Center and Research Institute|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Graft Versus Host Disease | 2007-12 | PHASE2 |
| NCT03467386 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Myeloid Leukemia | 2018-03-19 | PHASE1 |
| NCT02334488 | Poitiers University Hospital | Chronic Kidney Disease | 2014-12-11 | PHASE3 |
| NCT00086346 | Wyeth is now a wholly owned subsidiary of Pfizer | Liver Transplantation | 2002-12 | PHASE3 |
| NCT00928018 | Dana-Farber Cancer Institute|Brigham and Women´s Hospital|Massachusetts General Hospital|National Cancer Institute (NCI) | Non-hodgkin Lymphoma|Hodgkin Lymphoma | 2009-06 | PHASE3 |
| NCT00782379 | Northside Hospital, Inc. | Leukemia|Lymphoma|Myelodysplastic Syndromes | 2008-10 | PHASE2 |
| NCT06084780 | Case Comprehensive Cancer Center | Secondary Malignant Neoplasm of Retroperitoneum|Secondary Malignant Neoplasm of Peritoneum|Pseudomyxoma Peritonei | 2026-08 | PHASE2 |
| NCT00545493 | University Hospital, Bonn|Octapharma|Astellas Pharma GmbH | Rasmussen Encephalitis | 2002-11 | PHASE2|PHASE3 |
| NCT02558452 | Klemens Budde|Dr. med. univ. L. J. Lehner|Charite University, Berlin, Germany|ERA-EDTA|DESCARTES Working Group On Transplantation|European Kidney Transplant Association (EKITA) | Graft Failure|Death|Acute Rejection of Renal Transplant|Infections|Bone Disease|Post Transplant Diabetes Mellitus|Quality of Life|HLA Antibody Production|Cardiovascular Risk Factors|Non-HLA Antibody Production | 2016-12 | |
| NCT01128335 | Novartis Pharmaceuticals | Liver Transplantation | 2010-04 | PHASE2 |
| NCT00369382 | Wyeth is now a wholly owned subsidiary of Pfizer | Graft Rejection|Kidney Failure | 2006-09 | PHASE4 |
| NCT04080076 | NephroNet, Inc.|Mallinckrodt | Renal Disease | 2019-01-12 | PHASE4 |
| NCT04444817 | University Hospital Heidelberg | Liver Transplantation | 2018-11-22 | |
| NCT00223015 | University Hospital Schleswig-Holstein | Renal Transplantation | 2004-05 | PHASE4 |
| NCT04225988 | Cedars-Sinai Medical Center|Veloxis Pharmaceuticals | Kidney Transplant Rejection | 2020-01-09 | PHASE4 |
| NCT00919503 | Fred Hutchinson Cancer Center|medac GmbH|National Cancer Institute (NCI)|National Heart, Lung, and Blood Institute (NHLBI) | Non-Neoplastic Hematologic and Lymphocytic Disorder | 2009-07-31 | PHASE2 |
| NCT04788641 | AstraZeneca|Parexel | Hyperkalaemia | 2021-03-30 | PHASE1 |
| NCT03699631 | Medical College of Wisconsin|National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI) | Hematologic Malignancy | 2018-11-06 | PHASE2 |
| NCT03247088 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia | 2017-07-30 | PHASE1|PHASE2 |
| NCT03464435 | Zhongshan Ophthalmic Center, Sun Yat-sen University | Vernal Keratoconjunctivitis | 2016-11-01 | PHASE4 |
| NCT01518153 | M.D. Anderson Cancer Center | Leukemia|Lymphoma|Myeloma|Myeloproliferative Diseases | 2012-02 | PHASE2 |
| NCT03240822 | Wake Forest University Health Sciences | Urologic Injuries|Genital Diseases, Male|Amputation | 2017-01 | PHASE1 |
| NCT04339101 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Leukemia|Hematologic and Lymphocytic Disorder|Myelodysplastic Syndrome|Primary Myelofibrosis|Secondary Myelofibrosis | 2020-11-11 | PHASE2 |
| NCT05707377 | BeOne Medicines | Primary Membranous Nephropathy | 2023-04-17 | PHASE2|PHASE3 |
| NCT00002831 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Leukemia | 1995-08-01 | PHASE1|PHASE2 |
| NCT02224872 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Severe Aplastic Anemia|Bone Marrow Failure Syndromes | 2014-08 | PHASE2 |
| NCT00543569 | Astellas Pharma Inc | Kidney Transplantation | 2008-02 | PHASE2 |
| NCT00177138 | University of Minnesota|Bayer|Gruessner, Rainer, MD | Diabetes Mellitus | 2004-07 | PHASE4 |
| NCT02345850 | National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI) | Acute Leukemia|Myelodysplasia | 2015-08 | PHASE3 |
| NCT07249346 | Hannah Choe, MD|Incyte Corporation | Leukemia|Myelodysplasia|Chronic Myelomonocytic Leukemia | 2026-06-01 | PHASE2 |
| NCT04877288 | Bristol-Myers Squibb | Renal Allograft Recipients | 2021-07-21 | PHASE3 |
| NCT01680861 | Gaetano Ciancio | Transplant; Failure, Kidney | 2012-11 | PHASE3 |
| NCT03823768 | Medical University of South Carolina|Veloxis Pharmaceuticals | Neurotoxicity|Liver Transplant; Complications | 2020-01-31 | PHASE4 |
| NCT04341038 | Hospital Universitari de Bellvitge|Institut d´Investigació Biomèdica de Bellvitge | COVID-19|Lung Injury | 2020-04-01 | PHASE3 |
| NCT00803010 | H. Lee Moffitt Cancer Center and Research Institute | Acute Graft Versus Host Disease | 2008-09 | PHASE2 |
| NCT01490723 | M.D. Anderson Cancer Center|Spectrum Pharmaceuticals, Inc | Leukemia|Lymphoma | 2013-01 | PHASE2 |
| NCT01342289 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Hodgkin´s Lymphoma|Leukemia|Myelodysplastic Syndrome(MDS)|Multiple Myeloma|Non Hodgkin´s Lymphoma | 2011-08 | PHASE1 |
| NCT01131988 | Dr. Reddy´s Laboratories Limited | Healthy | 2008-01 | PHASE1 |
| NCT02075242 | Asan Medical Center | HEPATITIS | 2014-01 | PHASE4 |
| NCT00707759 | Fondo Nacional de Desarrollo Científico y Tecnológico, Chile | Kidney Diseases | 2008-06 | PHASE3 |
| NCT00448357 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI)|Otsuka America Pharmaceutical | Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2005-10 | PHASE1|PHASE2 |
| NCT00151632 | Rennes University Hospital|Ministry of Health, France | Evidence of Liver Transplantation | 2003-05 | PHASE3 |
| NCT04961801 | Shin Mineishi|Milton S. Hershey Medical Center | Lymphoma|Leukemia | 2022-03 | PHASE1|PHASE2 |
| NCT00709592 | Virginia Commonwealth University|Genzyme, a Sanofi Company | Non-Hodgkin´s Lymphoma|Leukemia|Multiple Myeloma|Acute Myeloid Leukemia|Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome | 2008-07-21 | PHASE2 |
| NCT01328834 | Sun Yat-sen University | Nephritis, Lupus | 2011-01 | PHASE3 |
| NCT01572662 | M.D. Anderson Cancer Center | Leukemia|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Lymphocytic Leukemia|Myeloproliferative Diseases|Non-Hodgkins Lymphoma|Hodgkins Lymphoma|Multiple Myeloma|Myelodysplastic Syndrome | 2012-04-11 | PHASE2 |
| NCT07285070 | Novaliq GmbH | Non-infectious Anterior Uveitis | 2026-03-16 | PHASE2 |
| NCT00014469 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Neoplasms | 2000-12 | PHASE2 |
| NCT01430065 | Astellas Pharma Inc | Pharmacokinetics of ASP015K|Drug Interactions|Healthy Subjects | 2009-06 | PHASE1 |
| NCT00801632 | National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN) | Kidney Transplantation|Kidney Failure, Chronic | 2008-12 | PHASE2 |
| NCT02880293 | Memorial Sloan Kettering Cancer Center | Hematologic Malignancy | 2016-08-23 | NA |
| NCT00321074 | Astellas Pharma Inc | LIVER TRANSPLANTATION | 2005-05 | PHASE3 |
| NCT00006350 | University of Maryland, Baltimore | Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 2000-01 | PHASE2 |
| NCT00078559 | University of Wisconsin, Madison|Immune Tolerance Network (ITN) | Kidney Transplantation|Kidney Disease | 2003-11 | PHASE1|PHASE2 |
| NCT02123108 | University of California, Los Angeles|Novartis | Liver Transplantation | 2011-01 | PHASE4 |
| NCT01092806 | University of Oslo School of Pharmacy|Oslo University Hospital | Post Transplant Diabetes Mellitus | 2009-10 | PHASE4 |
| NCT02555787 | Astellas Pharma Europe Ltd. | Kidney Transplantation | 2015-03-05 | |
| NCT06412497 | Masonic Cancer Center, University of Minnesota | Severe Aplastic Anemia|Acquired Amegakaryocytic Thrombocytopenia|Acquired Pure Red Cell Aplasia|Paroxysmal Nocturnal Hemoglobinuria | 2024-06-05 | PHASE2 |
| NCT02744378 | University of Peradeniya | Oral Lichen Planus | 2014-06 | PHASE2 |
| NCT01082393 | University Hospital, Ghent | Vitiligo | 2010-02-16 | PHASE4 |
| NCT01161459 | Zhi-Hong Liu, M.D. | Idiopathic Membranous Nephropathy | 2010-06 | NA |
| NCT00177099 | Hordinsky, Maria K., MD | Alopecia | 2003-07 | PHASE1 |
| NCT01647945 | Edda Spiekerkoetter|Stanford University | Pulmonary Arterial Hypertension | 2012-07 | PHASE2 |
| NCT00579111 | Baylor College of Medicine|Center for Cell and Gene Therapy, Baylor College of Medicine|The Methodist Hospital Research Institute | Myelodysplastic and Myeloproliferative Disorders|Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Multiple Myeloma|Plasma Cell Dyscrasia|Lymphoproliferative Disorders|Hematologic Diseases | 2007-06 | PHASE1|PHASE2 |
| NCT00040417 | Baylor College of Medicine|The Methodist Hospital Research Institute | Sickle Cell Anemia|Hemoglobinopathy|Thalassemia | 2000-08 | PHASE2 |
| NCT00056979 | Baylor College of Medicine|The Methodist Hospital Research Institute | Inherited Metabolic Storage Diseases | 2002-06 | PHASE1|PHASE2 |